
Laura Lynne Stockton
Examiner (ID: 6934)
| Most Active Art Unit | 1626 |
| Art Unit(s) | 2899, 1613, 1201, 1614, 1646, 1626 |
| Total Applications | 3246 |
| Issued Applications | 2197 |
| Pending Applications | 344 |
| Abandoned Applications | 753 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 7756847
[patent_doc_number] => 20120028959
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-02-02
[patent_title] => 'DIHYDROOROTATE DEHYDROGENASE INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 13/262640
[patent_app_country] => US
[patent_app_date] => 2010-03-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 38183
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0028/20120028959.pdf
[firstpage_image] =>[orig_patent_app_number] => 13262640
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/262640 | Dihydroorotate dehydrogenase inhibitors | Mar 25, 2010 | Issued |
Array
(
[id] => 9711074
[patent_doc_number] => 08835644
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-09-16
[patent_title] => 'Broad spectrum benzothiophene-nitrothiazolide and other antimicrobials'
[patent_app_type] => utility
[patent_app_number] => 13/257707
[patent_app_country] => US
[patent_app_date] => 2010-03-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 34
[patent_figures_cnt] => 54
[patent_no_of_words] => 39021
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13257707
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/257707 | Broad spectrum benzothiophene-nitrothiazolide and other antimicrobials | Mar 15, 2010 | Issued |
Array
(
[id] => 6425044
[patent_doc_number] => 20100168107
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-07-01
[patent_title] => 'IMIDAZOLE COMPOUNDS FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERS'
[patent_app_type] => utility
[patent_app_number] => 12/723204
[patent_app_country] => US
[patent_app_date] => 2010-03-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 39465
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0168/20100168107.pdf
[firstpage_image] =>[orig_patent_app_number] => 12723204
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/723204 | Imidazole compounds for the treatment of neurodegenerative disorders | Mar 11, 2010 | Issued |
Array
(
[id] => 7555713
[patent_doc_number] => 08067614
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-11-29
[patent_title] => 'N-substituted (benzoimidazol-2-yl)phenylamines, processes for their preparation, their use as a medicament or diagnostic aid, and a medicament comprising them'
[patent_app_type] => utility
[patent_app_number] => 12/722634
[patent_app_country] => US
[patent_app_date] => 2010-03-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6234
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/067/08067614.pdf
[firstpage_image] =>[orig_patent_app_number] => 12722634
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/722634 | N-substituted (benzoimidazol-2-yl)phenylamines, processes for their preparation, their use as a medicament or diagnostic aid, and a medicament comprising them | Mar 11, 2010 | Issued |
Array
(
[id] => 6320485
[patent_doc_number] => 20100196368
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-08-05
[patent_title] => 'SUBSTITUTED BENZ-AZOLES AND METHODS OF THEIR USE AS INHIBITORS OF RAF KINASE'
[patent_app_type] => utility
[patent_app_number] => 12/723483
[patent_app_country] => US
[patent_app_date] => 2010-03-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 55984
[patent_no_of_claims] => 52
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0196/20100196368.pdf
[firstpage_image] =>[orig_patent_app_number] => 12723483
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/723483 | Substituted benz-azoles and methods of their use as inhibitors of RAF kinase | Mar 11, 2010 | Issued |
Array
(
[id] => 8056255
[patent_doc_number] => 20120077863
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-03-29
[patent_title] => 'GUANIDINO-SUBSTITUTED BI-AND POLYPHENYLS AS SMALL MOLECULE CARRIERS'
[patent_app_type] => utility
[patent_app_number] => 13/203667
[patent_app_country] => US
[patent_app_date] => 2010-03-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 14372
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0077/20120077863.pdf
[firstpage_image] =>[orig_patent_app_number] => 13203667
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/203667 | GUANIDINO-SUBSTITUTED BI-AND POLYPHENYLS AS SMALL MOLECULE CARRIERS | Feb 28, 2010 | Abandoned |
Array
(
[id] => 7778496
[patent_doc_number] => 20120040977
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-02-16
[patent_title] => 'INHIBITORS OF HCV NS5A'
[patent_app_type] => utility
[patent_app_number] => 13/202726
[patent_app_country] => US
[patent_app_date] => 2010-02-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22905
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0040/20120040977.pdf
[firstpage_image] =>[orig_patent_app_number] => 13202726
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/202726 | INHIBITORS OF HCV NS5A | Feb 21, 2010 | Abandoned |
Array
(
[id] => 6236881
[patent_doc_number] => 20100267800
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-10-21
[patent_title] => 'N-Alkyl-Hydroxamic Acid-Isoindolyl Compounds and Their Pharmaceutical Uses'
[patent_app_type] => utility
[patent_app_number] => 12/705527
[patent_app_country] => US
[patent_app_date] => 2010-02-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25795
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0267/20100267800.pdf
[firstpage_image] =>[orig_patent_app_number] => 12705527
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/705527 | N-alkyl-hydroxamic acid-isoindolyl compounds and their pharmaceutical uses | Feb 11, 2010 | Issued |
Array
(
[id] => 6499646
[patent_doc_number] => 20100215616
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-08-26
[patent_title] => 'Hepatitis C Virus Inhibitors'
[patent_app_type] => utility
[patent_app_number] => 12/701919
[patent_app_country] => US
[patent_app_date] => 2010-02-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 65859
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0215/20100215616.pdf
[firstpage_image] =>[orig_patent_app_number] => 12701919
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/701919 | Hepatitis C virus inhibitors | Feb 7, 2010 | Issued |
Array
(
[id] => 8577944
[patent_doc_number] => 08344154
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-01-01
[patent_title] => '2-thioethenyl substituted carbapenem derivatives'
[patent_app_type] => utility
[patent_app_number] => 12/656606
[patent_app_country] => US
[patent_app_date] => 2010-02-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 45028
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12656606
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/656606 | 2-thioethenyl substituted carbapenem derivatives | Feb 3, 2010 | Issued |
Array
(
[id] => 6267630
[patent_doc_number] => 20100298390
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-11-25
[patent_title] => 'INHIBITION OF LETHAL FACTOR PROTEASE ACTIVITY FROM ANTHRAX TOXIN'
[patent_app_type] => utility
[patent_app_number] => 12/699082
[patent_app_country] => US
[patent_app_date] => 2010-02-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 11070
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0298/20100298390.pdf
[firstpage_image] =>[orig_patent_app_number] => 12699082
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/699082 | INHIBITION OF LETHAL FACTOR PROTEASE ACTIVITY FROM ANTHRAX TOXIN | Feb 2, 2010 | Abandoned |
Array
(
[id] => 6097760
[patent_doc_number] => 20110003807
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-01-06
[patent_title] => 'Thiazole derivatives'
[patent_app_type] => utility
[patent_app_number] => 12/657854
[patent_app_country] => US
[patent_app_date] => 2010-01-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 136264
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0003/20110003807.pdf
[firstpage_image] =>[orig_patent_app_number] => 12657854
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/657854 | Thiazole derivatives | Jan 27, 2010 | Issued |
Array
(
[id] => 6537887
[patent_doc_number] => 20100204260
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-08-12
[patent_title] => 'Multi-Substituted Imidazolines And Method Of Use Thereof'
[patent_app_type] => utility
[patent_app_number] => 12/694027
[patent_app_country] => US
[patent_app_date] => 2010-01-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 14377
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0204/20100204260.pdf
[firstpage_image] =>[orig_patent_app_number] => 12694027
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/694027 | Multi-substituted imidazolines and method of use thereof | Jan 25, 2010 | Issued |
Array
(
[id] => 6448415
[patent_doc_number] => 20100280075
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-11-04
[patent_title] => 'PACLITAXEL ENHANCER COMPOUNDS'
[patent_app_type] => utility
[patent_app_number] => 12/692895
[patent_app_country] => US
[patent_app_date] => 2010-01-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 27
[patent_figures_cnt] => 27
[patent_no_of_words] => 13829
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0280/20100280075.pdf
[firstpage_image] =>[orig_patent_app_number] => 12692895
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/692895 | Paclitaxel enhancer compounds | Jan 24, 2010 | Issued |
Array
(
[id] => 7663739
[patent_doc_number] => 20110313008
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-12-22
[patent_title] => 'PENTAFLUOROSULPHOLANE-CONTAINING ANTIDIABETIC COMPOUNDS'
[patent_app_type] => utility
[patent_app_number] => 13/145025
[patent_app_country] => US
[patent_app_date] => 2010-01-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15422
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0313/20110313008.pdf
[firstpage_image] =>[orig_patent_app_number] => 13145025
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/145025 | PENTAFLUOROSULPHOLANE-CONTAINING ANTIDIABETIC COMPOUNDS | Jan 20, 2010 | Abandoned |
Array
(
[id] => 7574050
[patent_doc_number] => 20110269706
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-11-03
[patent_title] => 'Hydroxamic Acid Derivatives'
[patent_app_type] => utility
[patent_app_number] => 13/143155
[patent_app_country] => US
[patent_app_date] => 2010-01-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15461
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0269/20110269706.pdf
[firstpage_image] =>[orig_patent_app_number] => 13143155
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/143155 | Hydroxamic acid derivatives | Jan 6, 2010 | Issued |
Array
(
[id] => 7680666
[patent_doc_number] => 20100105920
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-04-29
[patent_title] => 'PREPARATION OF ISOXAZOLIN-3-YLACYLBENZENES'
[patent_app_type] => utility
[patent_app_number] => 12/651946
[patent_app_country] => US
[patent_app_date] => 2010-01-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14386
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0105/20100105920.pdf
[firstpage_image] =>[orig_patent_app_number] => 12651946
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/651946 | Preparation of isoxazolin-3-ylacylbenzenes | Jan 3, 2010 | Issued |
Array
(
[id] => 7680664
[patent_doc_number] => 20100105922
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-04-29
[patent_title] => 'PROCESS FOR PRODUCING FUSED IMIDAZOLE COMPOUND, REFORMATSKY REAGENT IN STABLE FORM, AND PROCESS FOR PRODUCING THE SAME'
[patent_app_type] => utility
[patent_app_number] => 12/648022
[patent_app_country] => US
[patent_app_date] => 2009-12-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 40172
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0105/20100105922.pdf
[firstpage_image] =>[orig_patent_app_number] => 12648022
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/648022 | Process for producing fused imidazole compound, reformatsky reagent in stable form, and process for producing the same | Dec 27, 2009 | Issued |
Array
(
[id] => 8876072
[patent_doc_number] => 08471038
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-06-25
[patent_title] => 'Bicyclic heterocyclic compound'
[patent_app_type] => utility
[patent_app_number] => 13/141301
[patent_app_country] => US
[patent_app_date] => 2009-12-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 44091
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13141301
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/141301 | Bicyclic heterocyclic compound | Dec 24, 2009 | Issued |
Array
(
[id] => 8214670
[patent_doc_number] => 08193367
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-06-05
[patent_title] => 'Polymorph of a pharmaceutical'
[patent_app_type] => utility
[patent_app_number] => 12/644439
[patent_app_country] => US
[patent_app_date] => 2009-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 6315
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 91
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/193/08193367.pdf
[firstpage_image] =>[orig_patent_app_number] => 12644439
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/644439 | Polymorph of a pharmaceutical | Dec 21, 2009 | Issued |